Table 2.
Clinical and laboratory data of participants with liver cirrhosis (n = 20)
|
Variable
|
Data
|
| Etiology | |
| Alcohol | 8 |
| Autoimmune hepatitis | 1 |
| Hepatitis C | 5 |
| Drug-induced | 4 |
| NASH | 2 |
| MELD | 11 ± 3 |
| CTP | |
| A | 19 |
| B | 1 |
| Signs1 | |
| Ascites | 2 |
| Esophageal varices | 4 |
| Fatigue | 6 |
| Palmar erythema | 1 |
| Jaundice | 2 |
| Laboratory data | |
| Albumin (g/dL) | 3.62 ± 0.55 |
| Total bilirubin (mg/dL) | 1.01 ± 0.50 |
| Indirect bilirubin (mg/dL) | 0.44 ± 0.16 |
| INR | 1.23 ± 0.25 |
| GGT (U/L) | 186.67 ± 274.75 |
| AST/SGOT (U/L) | 44.79 ± 32.75 |
| ALT/SGPT (U/L) | 31.32 ± 19.01 |
| Creatinine (mg/dL) | 1.28 ± 1.48 |
1
Some participants had multiple signs while others showed none. Data are presented as mean ± SD. NASH: Nonalcoholic steatohepatitis; MELD: Model for End-stage Liver Disease; CTP: Child-Turcotte-Pugh; GGT: Gamma-glutamyl transferase; INR: International normalized ratio; AST: Aspartate aminotransferase; SGOT: Serum oxaloacetic transaminase; ALT: Alanine aminotransferase; SGPT: Serum glutamic-pyruvic transaminase.